HOME >> BIOLOGY >> NEWS
Climate change surprise: High carbon dioxide levels can retard plant growth, study reveals

The prevailing view among scientists is that global climate change may prove beneficial to many farmers and foresters at least in the short term. The logic is straightforward: Plants need atmospheric carbon dioxide to produce food, and by emitting more CO2 into the air, our cars and factories create new sources of plant nutrition that will cause some crops and trees to grow bigger and faster.

But an unprecedented three-year experiment conducted at Stanford University is raising questions about that long-held assumption. Writing in the journal Science, researchers concluded that elevated atmospheric CO2 actually reduces plant growth when combined with other likely consequences of climate change namely, higher temperatures, increased precipitation or increased nitrogen deposits in the soil.

The results of the study may prompt researchers and policymakers to re-think one of the standard arguments against taking action to prevent global warming: that natural ecosystems will minimize the problem of fossil fuel emissions by transferring large amounts of carbon in the atmosphere to plants and soils.

"Perhaps we won't get as much help with the carbon problem as we thought we could, and we will need to put more emphasis on both managing vegetation and reducing emissions," said Harold A. Mooney, the Paul S. Achilles Professor of Environmental Biology at Stanford and co-author of the Dec. 6 Science study.

He noted that the Stanford study is the first ecosystem-scale experiment to apply four climate change factors across several generations of plants.

"To understand complex ecological systems, the traditional approach of isolating one factor and looking at that response, then extrapolating to the whole system, is often not correct," Mooney said. "On an ecosystem scale, many interacting factors may be involved."

Jasper Ridge Global Change Project

The findings published in Science are among the first results of the Jas
'"/>

Contact: Mark Shwartz
mshwartz@stanford.edu
650-723-9296
Stanford University
5-Dec-2002


Page: 1 2 3 4

Related biology news :

1. Climate change plus human pressure caused large mammal extinctions in late Pleistocene
2. Climate change could doom Alaskas tundra
3. Climate may play role in lynxs hunting ability
4. Climate change Qs & As
5. Climate change may threaten more than one million species with extinction
6. Climate linked to reproduction of right whales
7. Climate change linked to migratory bird decrease
8. Climate affects recent crop yield gains
9. Climate and cholera: An increasingly important link
10. Grant from Vetlesen Foundation supports URI Graduate School of Oceanography Climate Research
11. Climate monitoring goes mobile

Post Your Comments:
(Date:7/7/2015)... , July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... the growing mobile commerce market announces a revised version of one ... The commercial will air on CNBC in New York ... and San Francisco metro areas. ... focuses on Wocket,s ability to replace all the cards in your ...
(Date:6/30/2015)... 2015 To bolster its efforts and commitment to ... today the addition of two new team members. ... and David Raviv will act as head of ... commitment to providing the most secure solutions for the enterprise ... Layer 7 Technologies, a provider of security and management products, ...
(Date:6/25/2015)... , June 25, 2015 ... Sensors Market by Type (Swipe & Area), Technology, Material ... Government, Healthcare, Commercial Security & Others) & Geography ... by marketsandmarkets, the said market is expected to ... of 17.1%. Browse 76 market ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... medicine company, is pleased to announce that the final ... have been locked.  Prototypes for industrial and regulatory ... an application for CE mark clearance to market ... in 2016. (Photo: http://photos.prnewswire.com/prnh/20150729/248373 )  ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... PRC Clinical, a Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi ... patient recruitment services. The core expertise of PRC Clinical is focused on Clinical ...
(Date:7/29/2015)... ... July 29, 2015 , ... Rainbow ... culture products, announces the availability of BI’s line of human mesenchymal stem cell ... stem cell differentiation media offer a complete system for multipotency evaluation of hMSCs ...
(Date:7/28/2015)... LONDON , July 29, 2015 ... on acquiring, rapidly developing and commercialising ... human health   Highly experienced management team; ...     Mereo BioPharma Group Ltd ... successfully raised $119m ( c. £76.5m), gross, from blue ...
Breaking Biology Technology:RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 3RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 4RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 5CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11
Cached News: